Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
出版年份 2023 全文链接
标题
Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
作者
关键词
-
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 251, Issue -, Pages 115226
出版商
Elsevier BV
发表日期
2023-03-01
DOI
10.1016/j.ejmech.2023.115226
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Deep Learning and Medical Image Analysis for COVID-19 Diagnosis and Prediction
- (2022) Tianming Liu et al. Annual Review of Biomedical Engineering
- Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study
- (2022) Mai H. ElNaggar et al. Marine Drugs
- Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors
- (2022) Hani A. Alhadrami et al. Marine Drugs
- Wuhan market was epicentre of pandemic’s start, studies suggest
- (2022) Amy Maxmen NATURE
- SARS-CoV-2 pathogenesis
- (2022) Mart M. Lamers et al. NATURE REVIEWS MICROBIOLOGY
- Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
- (2022) Daniel W. Kneller et al. Nature Communications
- Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
- (2022) Aranka V Ballering et al. LANCET
- Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
- (2022) Oliver J Watson et al. LANCET INFECTIOUS DISEASES
- The Acid Ceramidase Is a SARS-CoV-2 Host Factor
- (2022) Nina Geiger et al. Cells
- The Stereoselective Total Synthesis of Axially Chiral Naphthylisoquinoline Alkaloids
- (2022) Nasir Tajuddeen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
- (2022) Arun K. Ghosh et al. ChemMedChem
- Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19
- (2022) Annaliesa S. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies
- (2022) Bin Tan et al. Accounts of Chemical Research
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro
- (2021) Son Tung Ngo et al. Journal of Chemical Information and Modeling
- Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
- (2021) Hani A. Alhadrami et al. MOLECULES
- The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
- (2021) Melissa Zimniak et al. Scientific Reports
- Current Strategies of Antiviral Drug Discovery for COVID-19
- (2021) Miao Mei et al. Frontiers in Molecular Biosciences
- Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein
- (2021) Raha Orfali et al. Antibiotics-Basel
- Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
- (2021) Hani A. Alhadrami et al. Antibiotics-Basel
- Understanding COVID-19 vaccine hesitancy
- (2021) Shingai Machingaidze et al. NATURE MEDICINE
- Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
- (2021) Haixia Su et al. Nature Communications
- Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor
- (2021) Hani A. Alhadrami et al. Pharmaceuticals
- High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor
- (2021) Austin Clyde et al. Journal of Chemical Information and Modeling
- Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt
- (2021) Ragaey A. Eid et al. Antibiotics-Basel
- Ancistrosecolines A–F, Unprecedented seco-Naphthylisoquinoline Alkaloids from the Roots of Ancistrocladus abbreviatus, with Apoptosis-Inducing Potential against HeLa Cancer Cells
- (2020) Shaimaa Fayez et al. JOURNAL OF NATURAL PRODUCTS
- Updated Approaches against SARS-CoV-2
- (2020) Haiou Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
- (2020) Bhupesh Goyal et al. ACS Combinatorial Science
- Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products
- (2020) Phanankosi Moyo et al. International Journal for Parasitology-Drugs and Drug Resistance
- Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
- (2020) David M G Halpin et al. Lancet Respiratory Medicine
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Naphthylisoquinoline alkaloids and their synthetic analogs as potent novel inhibitors against Babesia canis in vitro
- (2020) Gerhard Bringmann et al. VETERINARY PARASITOLOGY
- Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
- (2020) Sk. Abdul Amin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Ancistrobrevidines A-C and related naphthylisoquinoline alkaloids with cytotoxic activities against HeLa and pancreatic cancer cells, from the liana Ancistrocladus abbreviatus
- (2020) Shaimaa Fayez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Induction of apoptosis in breast cancer cells by naphthylisoquinoline alkaloids
- (2020) Prem Prakash Kushwaha et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Antiplasmodial natural products: an update
- (2019) Nasir Tajuddeen et al. MALARIA JOURNAL
- Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells
- (2018) Shaimaa Fayez et al. FITOTERAPIA
- Ancistrolikokine E3, a 5,8′-Coupled Naphthylisoquinoline Alkaloid, Eliminates the Tolerance of Cancer Cells to Nutrition Starvation by Inhibition of the Akt/mTOR/Autophagy Signaling Pathway
- (2018) Suresh Awale et al. JOURNAL OF NATURAL PRODUCTS
- Dioncophyllines C2, D2, and F and Related Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ileboensis with Potent Activities against Plasmodium falciparum and against Multiple Myeloma and Leukemia Cell Lines
- (2017) Jun Li et al. JOURNAL OF NATURAL PRODUCTS
- Antiprotozoal Spirombandakamines A1 and A2, Fused Naphthylisoquinoline Dimers from a Congolese Ancistrocladus Plant
- (2017) Blaise Kimbadi Lombe et al. ORGANIC LETTERS
- Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko with antiausterity activities against PANC-1 human pancreatic cancer cells
- (2017) Shaimaa Fayez et al. RSC Advances
- OpenMM 7: Rapid development of high performance algorithms for molecular dynamics
- (2017) Peter Eastman et al. PLoS Computational Biology
- HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis
- (2016) Gerhard Bringmann et al. PHYTOCHEMISTRY
- Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells
- (2011) Alexander Cecil et al. GENOME BIOLOGY
- Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
- (2010) Gerhard Bringmann et al. CHEMICAL REVIEWS
- Ligand docking and binding site analysis with PyMOL and Autodock/Vina
- (2010) Daniel Seeliger et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Single-Molecule Pulling Simulations Can Discern Active from Inactive Enzyme Inhibitors
- (2010) Francesco Colizzi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Alterations to the structure of Leishmania major induced by N-arylisoquinolines correlate with compound accumulation and disposition
- (2009) A. Ponte-Sucre et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Structure−Activity Relationship and Studies on the Molecular Mechanism of LeishmanicidalN,C-Coupled Arylisoquinolinium Salts
- (2009) Alicia Ponte-Sucre et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started